We have observed two discrete populations of opiate receptors that are differently localized in rat brain. Morhine-like (mu) receptors, labeled by "25I-labeled [D-Ala-2MePhe4Met(Op-ollenkephalin, are concentrated selectively in lamina IV of the cerebral cortex, certain thalamic nuclei, and the Periaqueductal grey, while delta receptors, labeled by s25I-fabeled are (2) (3) (4) . The different drug affinities for enkephalin and opiate binding sites correspond to different pharmacological potencies in the mouse vas deferens (termed delta or enkephalin-like) and the guinea pig ileum (termed mu or morphine-like) (2). Protection experiments also distinguish mu-and delta-receptor binding sites in brain tissue (5). Differential tolerance of the mouse vas deferens to mu-and delta-specific drugs strongly supports the pharmacological relevance of the two receptors (6). Chang et al. (7, 8) labeled mu and delta receptors selectively with two 125I-labeled enkephalin analogs. A variety of opiates show different rank orders of potency for the two receptors, which also differ in regional distribution in rat brain (7, 8) . Various pharmacologic effects of certain enkephalin derivatives suggest that mu receptors mediate analgesic actions of opiates (9), while delta receptors may be responsible for epileptic (10, 11), sedative (1), and behavioral (10, 12) effects.
having high densities in cerebral cortex, corpus striatum, amygdala and olfactory tubercle. Because Based on pharmacologic effects in humans and spinally transected dogs, Martin et al. (1) have distinguished three opiate receptor effects that they designated mu, kappa, and sigma. Opiate binding studies also show multiple receptor sites; the properties of these, however, do not correspond to the pharmacologic distinctions described by Martin et (2) (3) (4) . The different drug affinities for enkephalin and opiate binding sites correspond to different pharmacological potencies in the mouse vas deferens (termed delta or enkephalin-like) and the guinea pig ileum (termed mu or morphine-like) (2) . Protection experiments also distinguish mu-and delta-receptor binding sites in brain tissue (5) . Differential tolerance of the mouse vas deferens to mu-and delta-specific drugs strongly supports the pharmacological relevance of the two receptors (6). Chang et al. (7, 8) labeled mu and delta receptors selectively with two 125I-labeled enkephalin analogs. A variety of opiates show different rank orders of potency for the two receptors, which also differ in regional distribution in rat brain (7, 8) . Various pharmacologic effects of certain enkephalin derivatives suggest that mu receptors mediate analgesic actions of opiates (9) , while delta receptors may be responsible for epileptic (10, 11) , sedative (1), and behavioral (10, 12) effects.
Larsson et al. (13) recently showed that met-and leu-enkephalin are contained, at least in part, in separate neuronal populations (13) . We (14) suggested that mu and delta receptors, respectively, are physiologic receptors for met-and leu-enkephalin neurons.
In the study reported here, we used a generally applicable, in vitro autoradiographic procedure developed by Young and Kuhar (15) to localize the two opiate receptors in rat brain. Mu and delta receptors are labeled preferentially with 125I-labeled enkephalin analogs (8) . We describe distinct differences in the localizations of mu and delta sites that correspond to differences in [Met] -and [Leulenkephalin neuronal localizations.
MATERIALS AND METHODS
In our autoradiographic procedure, the opiate receptors are labeled in intact, slide-mounted tissue sections on which binding can be assayed biochemically. Autoradiograms are generated by apposition of emulsion-coated coverslips (15) .
Sections (4-6,um) lective labeling of the delta receptors by 125I-DADL. Autoradiograms were exposed for 2-S weeks, and the developed sections were fixed, stained, and examined as described (15) . Assays of the binding of '25I-labeled enkephalin to brain membranes were conducted as reported (8, 16) . Reaction mixtures at 250C for 40 min (final volume was 0.25 ml) contained tissue suspension (final tissue concentration was 10 mg/ml), one of the 125I-labeled enkephalins (4-8 X 105 dpm/ml; about 0.1-0.2 nM), and buffer or 1 ,uM levallorphan.
125I-DADL and 125I-FK (both 1-2 Ci/,smol; 1 Ci = 3.7 X 1010 becquerels) were prepared and purified as described (17) . RESULTS Biochemical Studies. In our experiments, membrane binding properties of 125I-DADL and 125I-FK resemble those reported earlier (7, 8 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Similar regional differences in the binding ratios of the iodinated enkephalins occur in tissue sections as in membranes (l25I-DADL/l25I-FK is 1:2.3 for thalamic sections and 1:1.3 for frontal cortex sections).
Autoradiographic Studies. The percentage occupancy of the mu and delta receptors by the l25I-labeled ligand in each of the three conditions used can be estimated from the apparent dissociation constants (Kds) of the ligands for the two receptors (Figs. 1 and 2) . In both sagittal and coronal sections, mu receptors are selectively concentrated in laminae I and IV, whereas delta receptors are preferentially localized to laminae II, III, and V and show very little if any labeling in laminae I and IV.
In the caudate putamen, mu receptors are highly localized to discrete clusters and a subcallosal streak observed in earlier autoradiographic studies (15) . In contrast, delta receptors are more diffusely distributed throughout the caudate putamen; there is significant 125I-DADL labeling in areas between the mu-receptor clusters. In the caudate putamen and cerebral The receptor distribution seen in the cerebral cortex (laminae I and IV, labeled I and IV) and corpus striatum corresponds to that seen in Fig. 1 . For instance, the subcallosal streak and clusters appear to be mostly due to mu receptors. Labeling of mu receptors in the pyramidal cell layer of the hippocampus can be seen (B), but little labeling of delta receptors in hippocampus is seen (A). (Note that the overall intensity of the labeling in the corpus striatum is similar in A and B.) Comparison of the intensity of labeling in the hypothalamus and the dorsomedial and ventral thalamus with that in the corpus striatum shows that these areas are greatly enriched in mu receptors. cortex, as well as all other areas, sections incubated with 125I-DADL only display autoradiographic grains associated with both mu and delta receptors (Fig. 1A) .
The most striking contrast between mu-and delta-receptor localization occurs in the thalamus and hypothalamus (Fig. 2) . The dorsomedial and ventral thalamus, as well as the hypothalamus, display very high concentrations of mu receptors and extremely few delta receptors, resembling the biochemical results (8) . The hippocampal mu receptors are highly localized to the pyramidal cell layer, a localization not observed earlier (15) , presumably because of lesser sensitivity. Neurophysiologic effects of opiates in hippocampus are localized to interneurons adjacent to the pyramidal cells (18) . Delta receptors are more diffusely distributed and low in density in the hippocampus. In contrast to the thalamus and hypothalamus, which are selectively enriched in mu receptors, the olfactory tubercle, nucleus accumbens (Fig. 1) , and amygdala (not shown) have high densities of delta receptors and relatively few mu sites. In most brainstem areas, densities of mu receptors greatly exceed those of delta sites (Fig. 3) . Areas most enriched in mu receptors include the interpeduncular nucleus, midbrain median raphe, inferior colliculus, and periaqueductal grey; the concentration of mu receptors in the pontine nuclei is fairly low. Delta receptors are enriched only in the pontine nuclei. Apparent delta receptor labeling in the interpeduncular nucleus and inferior colliculus may represent "spill over" from the greatly enriched mu receptor densities in this region.
In the medulla oblongata and spinal cord, mu-and deltareceptor densities are similar, which agrees with biochemical data in spinal cord (19) . There are high levels of both receptors in the nucleus tractus solitarius, vagal nerve fibers, and nucleus ambiguus and moderate levels in other grey matter areas (Fig.  4) . In the spinal cord, there are high densities of both mu and delta receptors in the substantia gelatinosa and moderate densities throughout the grey matter (Fig. 5) .
Adjacent sections produced by incubations in the presence of 1 ,gM naloxone (Fig. 5C) show background levels in all of the areas discussed above, comparable to levels in white matter.
GTP (10 ,M) greatly decreases the binding of both 125I-labeled ligands, consistent with their agonist properties. DISCUSSION
The major finding of this study is that mu and delta opiate receptors are differentially localized throughout rat brain ( Table   1 ). The localization of mu receptors found resembles that found for opiate receptors in previous autoradiographic studies in this laboratory, in which the conditions used resulted in labeling of mu receptors primarily (15, 20) . The evidence that the two receptors are labeled preferentially by 125I-DADL and 125I-FK derives in part from biochemical studies (2) (3) (4) 8) .
The autoradiographic data reinforce other evidence that mu and delta receptors have different functions. For instance, mu-selective enkephalin analogs are more potent analgesics than delta-selective peptides (9), which agrees with our obser- The ratio of this density to that in other areas shown in A is much greater than the same ratio shown in B, indicating an enrichment of delta receptors in the pontine nuclei. The moderate labeling of the inferior colliculus and interpeduncular nucleus (A) occurs peptides. Interestingly, some limbic structures (such as the amygdala, nucleus accumbens, and olfactory tubercle) are enriched in delta receptors.
The mu-and delta-receptor dichotomy does not seem to fit with the pharmacologic classification of mu, kappa, and sigma receptors (1) . The distinct high-and low-affinity opiate receptors, which differentially regulate opiate analgesia and respiratory depression (21) , may represent mu and delta sites, respeclively, because regional variations in high-and low-affinity sites parallel those for mu and delta receptors (22) .
Evidence for distinct mu and delta receptors is strong. (ii) Mu receptors are more markedly regulated by sodium and GTP than are delta receptors (7, 14, 23) .
(iii) Regional variations in biochemical binding studies (8) :
ratio of mu to delta-thalamus = hypothalamus > brain stem = hippocampus > cerebral cortex = corpus striatum (ratio for cerebral cortex = 1).
(iv) Pharmacologic responses: predominantly mu in guinea pig ileum (2) vs. delta in mouse vas deferens (2), rabbit intestine ion flux (24) , and neuroblastoma adenylate cyclase (25) .
(v) Lack of cross tolerance between mu-and delta-specific drugs in regulation of mouse vas deferens contractions (6) .
(vi) Mu-selective enkephalin analogs are more analgesic (9) vs. delta-selective peptides are more epileptogenic (10, 11) and involved in reward systems (12 
